Lymphome Cérébral Primitif (LCP) du Sujet Immunocompétent: A Propos d’Un cas à l’Hôpital National de Niamey (HNN)
Keywords:
Lymphome Cérébral Primitif, Hôpital National de Niamey, Niamey-Niger
Abstract
Le Lymphome Cérébral Primitif (LCP) du sujet immunocompétent est une entité rare des lymphomes Non Hodgkiniens en général et des tumeurs cérébrales en particulier. Il est caractérisé par sa sévérité clinique, mais aussi son mauvais pronostic. Nous rapportons un cas de LCP chez un sujet immunocompétent diagnostiqué au service de neurologie et pris en charge au service d’Onco-hématologie de l’Hôpital National de Niamey.
Primary Cerebral Lymphoma (PCL) of the immunocompetent subject is a rare feature of non-Hodgkin's lymphoma in general and brain tumors in particular. It is characterized by its clinical severity, but also its poor prognosis. We report a case of LCP in an immunocompetent subject diagnosed in the neurology department and managed by Onco-hematology at the National Hospital of Niamey.
Downloads
Download data is not yet available.
Metrics
Metrics Loading ...
References
1. Haldorsen IS, Krossness BK, Aarseth JH. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003: time trends in a 15-YEAR national survery. Cancer 2007;110:1803-14
2. Cote TR, Manns A, Hardy CR, Yellin FJ, Hartge P.Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst 1996;88:675-9
3. Kadan Lottick NS, Skluzacek MC, Gurney JG, Decreasing incidence rates of primary central nervous system lymphoma. Cancer 2002;95:193-202.
4. Jones IL, Hanson DL, workin MS, Ward JW.Effect of antiretroviral therapy on recent trends in selected cancers among HIV infected persons. Adult/Adolescent Spectrum of HIV Disrase Project Group. J Acquir Immune Defic Syndr 1999;21(suppl):S11-S17.
5. Ferreri AJ, BlayJY, Reni M. Prognostic scoring system for primary CNS lymphomas:the Internatinal Extranodal Lymphoma Study Group experience. J Clin Oncol 2003;21:266-72.
6. Abrey LE, Ben Porat L, Panageas KS. Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer center prognostic model. J Clin oncol 2006;24:5711-5.
7. Bataille B, Delwail V, Menet E. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 200;92:261-6.
8. Bromberg JE, Siemers MD, Taphoorn MJ. Is a ‘vanishing tumor’ always a lymphoma? Neurology 2002;59:762-4.
9. Ferreri AJ, Reni M, Zoldan MC, Terreni MR. Importance of complete staging in non-Hodgkin’s lymphoma presenting as a cerebral masse lesion. Cancer 1996;77:827-33.
10. Herrlinger U. Primary CNS lymphoma: findings outside the brain. J Neurooncol 1999;43:227-30.
11. O’Neill BP, Dinapoli RP, Kurtin PJ. Occult systemic non-Hodgkin’s lymphoma (NHL) in patient initially diagnosed as primary central nervous system lymphoma (PCNSL): how much staging is enough? J Neuroncol 1995;25:67-71.
12. Abrey LE, Batcheler TT, Ferreri AJ. Repport of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin oncol 2005;23:5034-43.
13. Mead GM, Bleehen NM, Gregor A. A medical research council randomized trial in patient with primary cerebral non-Hodgkin lymphoma cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy. Cancer 2000;89:1359-70.
14. Laperriere NJ, Cerezo L, Milosevic MF. Prilmary Lymphoma of brain: result of management of a modern cohort with radiation therapy. Radiother Oncol 1997;43:247-52.
15. Nelson DF, Martz KL, Bonner H. Non-Hodgkin’s lymphoma of brain: can high dose, large volume radiation therapy improves survival? Report of on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 1992;23:9-17.
16. Corry J, Smith JG, Wirth A. Primary centre nervous system lymphoma: age and perfrormance status are more important than treatement modality. Int J Rdiat Oncol Biol Phys 1998;41:615-20.
17. Shibamoto Y, Ogino H, Hasegawa M Results of radiation monothérapy for primary central nervous system lymphoma in the 1990s Int J Radiat Oncol Biol Phys 2005;62:809-13.
18. Blay JY, Conroy T, Chevrau T. High dose methotrexate for the treatement of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol 1998;16:864-71.
19. O’Neill BP, O’Fallon JR, Earle JD. Primary central nervous system no-Hodgkin’s lymphoma: survival advantages with combined initial theray? Int J Radiat Oncol Biol Phys 1995;33:663-73.
2. Cote TR, Manns A, Hardy CR, Yellin FJ, Hartge P.Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst 1996;88:675-9
3. Kadan Lottick NS, Skluzacek MC, Gurney JG, Decreasing incidence rates of primary central nervous system lymphoma. Cancer 2002;95:193-202.
4. Jones IL, Hanson DL, workin MS, Ward JW.Effect of antiretroviral therapy on recent trends in selected cancers among HIV infected persons. Adult/Adolescent Spectrum of HIV Disrase Project Group. J Acquir Immune Defic Syndr 1999;21(suppl):S11-S17.
5. Ferreri AJ, BlayJY, Reni M. Prognostic scoring system for primary CNS lymphomas:the Internatinal Extranodal Lymphoma Study Group experience. J Clin Oncol 2003;21:266-72.
6. Abrey LE, Ben Porat L, Panageas KS. Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer center prognostic model. J Clin oncol 2006;24:5711-5.
7. Bataille B, Delwail V, Menet E. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 200;92:261-6.
8. Bromberg JE, Siemers MD, Taphoorn MJ. Is a ‘vanishing tumor’ always a lymphoma? Neurology 2002;59:762-4.
9. Ferreri AJ, Reni M, Zoldan MC, Terreni MR. Importance of complete staging in non-Hodgkin’s lymphoma presenting as a cerebral masse lesion. Cancer 1996;77:827-33.
10. Herrlinger U. Primary CNS lymphoma: findings outside the brain. J Neurooncol 1999;43:227-30.
11. O’Neill BP, Dinapoli RP, Kurtin PJ. Occult systemic non-Hodgkin’s lymphoma (NHL) in patient initially diagnosed as primary central nervous system lymphoma (PCNSL): how much staging is enough? J Neuroncol 1995;25:67-71.
12. Abrey LE, Batcheler TT, Ferreri AJ. Repport of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin oncol 2005;23:5034-43.
13. Mead GM, Bleehen NM, Gregor A. A medical research council randomized trial in patient with primary cerebral non-Hodgkin lymphoma cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy. Cancer 2000;89:1359-70.
14. Laperriere NJ, Cerezo L, Milosevic MF. Prilmary Lymphoma of brain: result of management of a modern cohort with radiation therapy. Radiother Oncol 1997;43:247-52.
15. Nelson DF, Martz KL, Bonner H. Non-Hodgkin’s lymphoma of brain: can high dose, large volume radiation therapy improves survival? Report of on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 1992;23:9-17.
16. Corry J, Smith JG, Wirth A. Primary centre nervous system lymphoma: age and perfrormance status are more important than treatement modality. Int J Rdiat Oncol Biol Phys 1998;41:615-20.
17. Shibamoto Y, Ogino H, Hasegawa M Results of radiation monothérapy for primary central nervous system lymphoma in the 1990s Int J Radiat Oncol Biol Phys 2005;62:809-13.
18. Blay JY, Conroy T, Chevrau T. High dose methotrexate for the treatement of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol 1998;16:864-71.
19. O’Neill BP, O’Fallon JR, Earle JD. Primary central nervous system no-Hodgkin’s lymphoma: survival advantages with combined initial theray? Int J Radiat Oncol Biol Phys 1995;33:663-73.
Published
2023-06-23
How to Cite
Sidibé, O. H., Djibrilla, A., Kélani, A., Malam-Abdou, B., & Daou, M. (2023). Lymphome Cérébral Primitif (LCP) du Sujet Immunocompétent: A Propos d’Un cas à l’Hôpital National de Niamey (HNN). European Scientific Journal, ESJ, 18, 589. Retrieved from https://eujournal.org/index.php/esj/article/view/16899
Section
ESI Preprints
Copyright (c) 2023 O. H. Sidibé, A. Djibrilla, A. Kélani, B. Malam-Abdou, M. Daou
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
.jpg)
